Hyoung Kim is an Oncology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 165 publications with 2,655 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8775 Norwin Ave Ste J
Suite 102
North Huntingdon, PA 156422718
Telephone
724-834-1463Registry record last updated 15 Jun 2021.
Clinical trials
- Articulated Laparoscopic Instruments Clinical Study
Sponsor: Yonsei University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- Exelixis Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
87.3%Iron, parenteral preparations86.4%Ferric carboxymaltose100%Part B, office-administered≥12 patientsFactor Xa inhibitor0.7%Eliquis58%Xarelto42%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
5.6%Serotonin-3 Receptor Antagonist5.4%Granisetron hydrochloride97%Ondansetron Hcl3%Part D + Part B≥20 patientsCorticosteroid0.1%Prednisone100%Part D<11 patients+ 1 more class in this area
Sensory organs
5.3%Corticosteroid5.3%Dexamethasone sodium phosphate100%Part B, office-administered≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”